Status: Recruiting
A Study of Single and Multiple Subcutaneous or Intravenous Doses of ADX-001 in Healthy Adults to Assess Safety, Effects, and Immune Response
This is a phase 1, randomized, double-blind, placebo-controlled, single and multiple ascending dose study to evaluate safety, tolerability, pharmacokinetics, pharmacodynamics and immunogenicity of subcutaneous and intravenous ADX-001 in healthy adult participants
Participants needed: 88
Trial details
Phase: Phase 1Age: 18-55Biological sex: AllType: InterventionalSponsor: Adaxion TherapeuticsUpdated: Oct 21, 2026Locations: 1
Eligibility criteria
Provide informed consent - Be willing and able to sign a consent form after unde... [+4]
Medical Conditions [+26]